|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.91 USD | -0.37% |
|
+0.80% | +99.26% |
| 15/05 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 21/04 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
| Market Cap | 9.04Cr 7.85Cr 7.32Cr 6.72Cr 13Cr 859.49Cr 13Cr 86Cr 34Cr 429.64Cr 34Cr 33Cr 1.42TCr | P/E 2026 * |
1.13x | P/E 2027 * | -5.44x |
|---|---|---|---|---|---|
| Enterprise Value | 9.04Cr 7.85Cr 7.32Cr 6.72Cr 13Cr 859.49Cr 13Cr 86Cr 34Cr 429.64Cr 34Cr 33Cr 1.42TCr | EV / Sales 2026 * |
1.13x | EV / Sales 2027 * | 0.73x |
| Free-Float |
77.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fortress Biotech, Inc.
| 1 day | -0.37% | ||
| 1 week | +0.80% | ||
| Current month | +0.16% | ||
| 1 month | -7.35% | ||
| 3 months | +34.30% | ||
| 6 months | +60.25% | ||
| Current year | +99.26% |
| 1 week | 18.7 |  | 19.08 |
| 1 month | 17.9 | | 20.35 |
| Current year | 9.49 | | 21.43 |
| 1 year | 6.27 | | 21.43 |
| 3 years | 4.72 | | 21.43 |
| 5 years | 4.72 | | 26.6 |
| 10 years | 0 | | 26.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 20/12/2013 | |
Xiao Qin Lu
DFI | Director of Finance/CFO | 51 | 22/02/2012 |
David Jin
DFI | Director of Finance/CFO | 36 | 16/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jimmie Harvey
BRD | Director/Board Member | 74 | 01/12/2008 |
| Chairman | 71 | 20/12/2013 | |
J. Jay Lobell
BRD | Director/Board Member | 63 | 01/06/2006 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.37% | +0.80% | - | - | 9.04Cr | |
| +0.19% | +9.42% | +33.09% | -0.75% | 7.6TCr | |
| +2.69% | -8.77% | +22.50% | +186.41% | 4.9TCr | |
| +3.72% | -4.71% | -8.40% | +20.60% | 4.79TCr | |
| +1.42% | +2.02% | -51.10% | -50.16% | 4.34TCr | |
| +3.29% | +1.38% | +57.68% | -22.49% | 3.08TCr | |
| +1.83% | -7.18% | +54.54% | +89.53% | 2.44TCr | |
| +3.36% | +2.12% | +106.19% | -47.32% | 2.28TCr | |
| +4.15% | +0.67% | -8.56% | +210.84% | 1.92TCr | |
| +0.60% | -7.19% | +59.71% | +117.00% | 1.59TCr | |
| Average | +2.08% | -0.84% | +29.52% | +55.96% | 3.66TCr | |
| Weighted average by Cap. | +2.10% | +0.79% | +22.18% | +43.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.99Cr 6.94Cr 6.47Cr 5.94Cr 11Cr 759.8Cr 11Cr 76Cr 30Cr 379.81Cr 30Cr 29Cr 1.26TCr | 12Cr 11Cr 9.96Cr 9.15Cr 17Cr 1.17TCr 17Cr 117.4Cr 46Cr 584.87Cr 46Cr 45Cr 1.94TCr |
| Net income | 9.05Cr 7.86Cr 7.33Cr 6.73Cr 13Cr 860.97Cr 13Cr 86Cr 34Cr 430.39Cr 34Cr 33Cr 1.43TCr | -2.08Cr -1.81Cr -1.69Cr -1.55Cr -2.93Cr -198.22Cr -2.96Cr -20Cr -7.78Cr -99Cr -7.83Cr -7.65Cr -328.31Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | $18.91 | -0.37% | 16,014 |
| 03/26/03 | $18.98 | +0.53% | 19,962 |
| 31/26/31 | $18.88 | +0.43% | 3,917 |
| 30/26/30 | $18.80 | -0.05% | 27,555 |
| 29/26/29 | $18.81 | +0.27% | 10,182 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBIO Stock
- FBIOP Stock
Select your edition
All financial news and data tailored to specific country editions
